The global market for continuous renal replacement therapy (CRRT) was valued at USD 1,356.7 million in 2022, with an expected compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. This growth is driven by several key factors, including the rising incidence of acute kidney injury (AKI), an increasing rate of sepsis, a rapid expansion of hospitals and urgent care centers, and a growing...